Stephanie Sutton

home / authors / stephanie-sutton-3

Stephanie Sutton was an assistant editor at Pharmaceutical Technology Europe.

Articles

Pharma's Most Productive Innovators: The Top Ten

February 11th 2013

Consultancy firm IDEA Pharma has released what it calls a ‘Productive Innovation Index’, which ranks pharmaceutical companies based on their ability to successfully commercialize new innovations.

European Commission Investigates J&J, Novartis

Stephanie Sutton

February 3rd 2013

The European Commission claims that Johnson & Johnson and Novartis may have breached European antitrust rules.

GSK Expands Vaccine Presence in China

Stephanie Sutton

June 16th 2011

GlaxoSmithKline has entered into an agreement to purchase Shenzhen Neptunus? stake in a previously formed joint venture between the companies involved in the development and manufacture of influenza vaccines in China, Hong Kong, and Macau.

Europe Launches Early Drug Development Pilot

Stephanie Sutton

October 29th 2010

A European pilot initiative will test the impact of consultations with a number of stakeholders such as patient representatives and payers on early stage drug development.

EU Generic Applications Down

Stephanie Sutton

August 19th 2010

August 20, 2010.

Sanofi Fights FDA Approval of Generic Lovenox

Stephanie Sutton

July 30th 2010

August 2, 2010.

Servier Back in EC's Anticompetitive Behaviour Spotlight

Stephanie Sutton

July 30th 2010

August 01, 2010. French pharma giant accused of providing "misleading" and "incorrect" information.

Lilly Moves into Enzyme Replacement Therapy

Stephanie Sutton

July 9th 2010

July 10, 2010.

Patent Cliff Pushes Pharma to the Brink

Stephanie Sutton

May 20th 2010

May 24, 2010.

EMA to Improve Benefit-Risk Assessments

Stephanie Sutton

April 29th 2010

April 29, 2010.

European Medicines Agency Praised in Evaluation

Stephanie Sutton

April 23rd 2010

April 21, 2010.

Regenerative Medicines Hold "Promise of Cures"

Stephanie Sutton

April 16th 2010

April 21, 2010.

Report Predicts Major Slowdown for Big Pharma

Stephanie Sutton

March 4th 2010

4 March, 2010

Positive Outlook for UK Biotech Jobs

February 26, 2010.

US-based CRO, Health Decisions, hopes to raise the efficacy standards for complex studies and help companies get products to market faster by establishing an international network of CROs.